Investors

Corporate Overview

Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. We are focused on becoming the standard of care for spine fusion surgery.

Share Price

NASDAQ GS: CARL
10.80 USD
-0.2 (-1.82%)
as of Jul 24, 2026 4:00 PM EDT
Minimum 15 minutes delayed. Source: LSEG
View Stock Performance

Recent News

• Jul 22, 2026\ \ Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026
• May 05, 2026\ \ Carlsmed® Reports First Quarter 2026 Financial Results
• Apr 28, 2026\ \ Carlsmed, Inc. To Participate in Upcoming Investor Conferences

Events

• Aug 5, 2026 4:30 PM EDT\ \ Carlsmed Second Quarter 2026 Earnings Conference Call
• Jun 16, 2026 10:00 AM EDT\ \ Truist Securities MedTech Conference\ \ Boston, MA
• Jun 4, 2026\ \ \ Jefferies Global Healthcare Conference\ \ New York, NY

The premier personalized solution

for spinal fusion

The only FDA designated Breakthrough

Technology for intervertebral spine fusion

AI-enabled

surgical planning